FORTE BIOSCIENCES, INC.
Income Statement
| Line Item | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|
| Revenue | $36.0K | $18.0M | $41.0K | $49.0K |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | $45.3M | $51.1M | $29.1M | $27.2M |
| SG&A Expense | $1.4M | $12.8M | $8.6M | $4.5M |
| Operating Income | $-4.1M | $-45.9M | $-37.6M | $-31.7M |
| Operating Margin | -11,288.9% | -254.2% | -91,775.6% | -64,673.5% |
| Interest Expense | $3.8M | $2.9M | $1.9M | $2.1M |
| Pretax Income | $-63.5M | $-47.3M | $-38.9M | $-33.5M |
| Income Tax Expense | $1.0K | $1.7M | $1.0K | $1.0K |
| Net Income | $-4.1M | $-49.0M | $-38.9M | $-33.5M |
| Net Margin | -11,302.8% | -271.4% | -94,948.8% | -68,322.4% |
| EPS (Basic) | $-1.93 | $-2.44 | $-2.66 | $-15.22 |
| EPS (Diluted) | $-1.93 | $-2.44 | $-2.66 | $-15.22 |
| Shares Outstanding (Basic) | 2.1M | 23.0M | 19.9M | 2.2M |
| Shares Outstanding (Diluted) | 2.1M | 23.0M | 19.9M | 2.2M |
| Dividends Per Share | — | — | — | — |